Mediclinic - a clinical uptrend

Has been in a consistent uptrend since July 2021. Points raised below.

- broke initial resistance level at ~6750
- tested twice the next resistance level at 7200
- on weekly chart, 50day MA about to break above 200day MA

One of the best looking charts on the JSE. I bought in yesterday (20220414) at 7263. Results should be released soon.

Trade active

Results released this morning (snippet below from SENS).

Highlights
- Strong financial performance driven by increased client activity
- Group revenue growth around 8% in the year and improved Group EBITDA margin
at around 16.0% (FY21: 14.2%)
- Recovery in profitability and strong cash conversion leading to significant
reduction in leverage ratio
- Expect positive momentum in client activity to drive revenue growth and margins
in the coming year

Trade active

*Remgro says Mediclinic's board of directors rejects Remgro's takeover offer of 460 pence

Trade closed: target reached

ArshadT

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.